Initial temozolomide for high-risk lowgrade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: A post-hoc analysis of the efficacy within molecular subgroups of WHO 2016

Category Primary study
JournalEuropean Journal of Neurology
Year 2020
This article has no abstract
Epistemonikos ID: dd0e507687a8920cd137f3b199267a696434adc1
First added on: Feb 12, 2025